Skip to content

RISE RCT for Nurse Leaders

A Randomized Controlled Trial of RISE for Nurse Leaders

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05254600
Acronym
RISE
Enrollment
80
Registered
2022-02-24
Start date
2022-03-28
Completion date
2023-05-15
Last updated
2023-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burnout, Stress

Brief summary

The purpose of this study is to determine whether RISE for Nurse Leaders has a significant impact on nurse leaders' post-traumatic growth, resilience, insight, self-compassion, and empowerment, as well as mental well-being, in their personal lives and their working environment.

Interventions

BEHAVIORALRISE for Nurse Leaders Program

Psychoeducational sessions designed to impact resilience, insight, self-compassion, and empowerment

Sponsors

AdventHealth
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult ≥ 18 years old * Licensed as an RN * Unit-based nurse leader (i.e., assistant nurse manager, nurse manager) employed by AdventHealth in a hospital-based setting at the Altamonte Springs, Apopka, Celebration, Daytona Beach, DeLand, East Orlando, Fish Memorial, Kissimmee, New Smyrna Beach, Orlando, Palm Coast, Waterman, or Winter Park campus * Able to speak, read, and understand English fluently * Able to provide informed consent * Willing and able to comply with all study procedures and requirements for the duration of the study.

Exclusion criteria

* Employed as a direct care nurse or in another level of nursing leadership (i.e., director of nursing, executive leader) * A study participant of IRBNet #1504917 titled A Pilot Study of RISE for Nurse Managers

Design outcomes

Primary

MeasureTime frameDescription
Posttraumatic Growth InventoryGroup comparison from baseline to 3-month follow-up21 item questionnaire with a scale of 0-5, with 0 meaning I did not experience this change as a result of my crisis; and 5 meaning I experienced this change to a very great degree as a result of my crisis

Secondary

MeasureTime frameDescription
Brief Resilience ScaleGroup comparison from baseline to 3-month follow-up6 item questionnaire with a scale of 1-5, with 1 meaning strongly disagree; and 5 meaning strongly agree
General Self-Efficacy ScaleGroup comparison from baseline to 3-month follow-up10 item questionnaire with a scale of 1-4, with 1 meaning not at all true; and 4 meaning exactly true
Perceived Stress ScaleGroup comparison from baseline to 3-month follow-up10 item questionnaire with a scale of 0-4, with 0 meaning never; and 4 meaning very often
Brief Index of Affective Job SatisfactionGroup comparison from baseline to 3-month follow-up4 item questionnaire with a scale of 1-5, with 1 meaning strongly disagree; and 5 meaning strongly agree
Psychological Empowerment InstrumentGroup comparison from baseline to 3-month follow-up12 item questionnaire with a scale of A-G, with A meaning very strongly disagree; and G meaning very strongly agree
Self-Reflection and Insight ScaleGroup comparison from baseline to 3-month follow-up20 item questionnaire with a scale of 1-6; with 1 meaning strongly disagree; and 6 meaning strongly agree
Professional Quality of Life (ProQOL) ScaleGroup comparison from baseline to 3-month follow-up30 item questionnaire with a scale of 1-5 with 1 meaning never; and 5 meaning very often

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026